Showing results (171-180 of 203) with videos related to

Sort By:
Pageof 21
International Journal of Molecular Sciences|January 16, 2014
Evaluation of hepatic tissue blood flow using xenon computed tomography with fibrosis progression in nonalcoholic fatty liver disease: comparison with chronic hepatitis CRyuta Shigefuku, Hideaki Takahashi, Masaki Kato, et al.
The Oncologist|April 6, 2023
Association Between Immune-Related Adverse Events and Survival in Patients with Hepatocellular Carcinoma Treated With Atezolizumab Plus BevacizumabTaito Fukushima, Manabu Morimoto, Satoshi Kobayashi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 15, 2010
A predictive model of response to peginterferon ribavirin in chronic hepatitis C using classification and regression tree analysisMasayuki Kurosaki, Kotaro Matsunaga, Itsuko Hirayama, et al.
Biology of Reproduction|April 1, 2025
Zinc eluted from glassware is a risk factor for embryo development in human and animal assisted reproduction†Tatsuma Yao, Hisato Kobayashi, Tatsuki Hirai, et al.
Anaerobe|August 22, 2017
Fusobacterium nucleatum detected simultaneously in a pyogenic liver abscess and advanced sigmoid colon cancerRyuta Shigefuku, Tsunamasa Watanabe, Yuki Kanno, et al.
Diabetes|March 2, 2018
Urinary IgG4 and Smad1 Are Specific Biomarkers for Renal Structural and Functional Changes in Early Stages of Diabetic NephropathyToshio Doi, Tatsumi Moriya, Yui Fujita, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|November 24, 2021
Prediction of esophagogastric varices associated with oxaliplatin administrationYosuke Satta, Ryuta Shigefuku, Tsunamasa Watanabe, et al.
Virus Research|July 7, 2020
The peripheral lymphocyte count as a predictor of severe COVID-19 and the effect of treatment with ciclesonideYukitaka Yamasaki, Seido Ooka, Tomoya Tsuchida, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|March 26, 2016
Can the Abbott RealTime hepatitis C virus assay be used to predict therapeutic outcomes in hepatitis C virus-infected patients undergoing triple therapy?Hiroki Ikeda, Chiaki Okuse, Tsunamasa Watanabe, et al.
Plos One|February 14, 2022
Serum miR-192-5p levels predict the efficacy of pegylated interferon therapy for chronic hepatitis BYoshihito Nagura, Kentaro Matsuura, Etsuko Iio, et al.
Pageof 21